125 related articles for article (PubMed ID: 10742838)
1. [18F-FDG whole-body positron-emission tomography (PET) in patients with unknown primary tumors].
Matheja P; Schober O
Strahlenther Onkol; 2000 Mar; 176(3):151-2. PubMed ID: 10742838
[No Abstract] [Full Text] [Related]
2. Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome).
Alberini JL; Belhocine T; Hustinx R; Daenen F; Rigo P
Nucl Med Commun; 2003 Oct; 24(10):1081-6. PubMed ID: 14508164
[TBL] [Abstract][Full Text] [Related]
3. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in unknown primary neoplasms].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S103-4. PubMed ID: 12739342
[No Abstract] [Full Text] [Related]
4. [Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors].
Shinohara M; Tomita M; Ohira S; Nishimura A
Hokkaido Igaku Zasshi; 1999 May; 74(3):249-56. PubMed ID: 10422568
[TBL] [Abstract][Full Text] [Related]
5. Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
Dede F; Ajoedi ND; Ansari SM; Jana S; Heiba SI; Abdel-Dayem HM
Clin Nucl Med; 2001 May; 26(5):396-9. PubMed ID: 11317017
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic osteoarthropathy on bone scintigraphy related to a mediastinal tumour of unknown origin imaged by FDG-PET.
Smit F; Valdés Olmos RA; Sivro-Prndelj F; Hoefnagel CA
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):332. PubMed ID: 12552357
[No Abstract] [Full Text] [Related]
7. FDG PET helpful for diagnosing SAPHO syndrome.
Kohlfuerst S; Igerc I; Lind P
Clin Nucl Med; 2003 Oct; 28(10):838-9. PubMed ID: 14508277
[No Abstract] [Full Text] [Related]
8. [Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
Barghouth G; Allaoua M; Goerres GW
Rev Med Suisse Romande; 2000 Jun; 120(6):535-42. PubMed ID: 11014099
[No Abstract] [Full Text] [Related]
9. Angiolipoma detected by F-18 FDG positron emission tomography.
Hsu CH; Yang CM; Cheng CJ
Clin Nucl Med; 2003 Jul; 28(7):604-5. PubMed ID: 12819423
[No Abstract] [Full Text] [Related]
10. [A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18-fluorodeoxyglucose helpful?].
Lorenzen J; Buchert R; Bleckmann C; Münchow N; Bohuslavizki KH
Rofo; 1999 Jul; 171(1):49-53. PubMed ID: 10464505
[TBL] [Abstract][Full Text] [Related]
11. [A case report. FDG-PET in occult breast cancer].
Ladjevardi S; Sörensen J; Hellman P; Juhlin C; Wärnberg F
Lakartidningen; 2002 Feb; 99(6):524-6. PubMed ID: 11881227
[No Abstract] [Full Text] [Related]
12. Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
Nguyen JD; Carrasquillo JA; Little RF; Ryan QC; Wilson W; Chen CC
Clin Nucl Med; 2003 Dec; 28(12):979-80. PubMed ID: 14663321
[No Abstract] [Full Text] [Related]
13. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU
Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840
[TBL] [Abstract][Full Text] [Related]
14. FDG PET detection of unknown primary tumors.
Bohuslavizki KH; Klutmann S; Kröger S; Sonnemann U; Buchert R; Werner JA; Mester J; Clausen M
J Nucl Med; 2000 May; 41(5):816-22. PubMed ID: 10809197
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
16. Detection of unknown occult primary tumors using positron emission tomography.
Kole AC; Nieweg OE; Pruim J; Hoekstra HJ; Koops HS; Roodenburg JL; Vaalburg W; Vermey A
Cancer; 1998 Mar; 82(6):1160-6. PubMed ID: 9506364
[TBL] [Abstract][Full Text] [Related]
17. Guest editorial: the conception of FDG-PET imaging.
Alavi A; Reivich M
Semin Nucl Med; 2002 Jan; 32(1):2-5. PubMed ID: 11839067
[No Abstract] [Full Text] [Related]
18. 18-FDG PET-CAT scan detection of unknown primary tumor. A case report.
Menaldo G; Rubello D; Toso S; Migliorini V; Ravasi MA
Suppl Tumori; 2005; 4(3):S168. PubMed ID: 16437966
[No Abstract] [Full Text] [Related]
19. Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET.
Tatsumi M; Clark PA; Nakamoto Y; Wahl RL
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):40-5. PubMed ID: 12483408
[TBL] [Abstract][Full Text] [Related]
20. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
